Last Price$11.10.1%
Market Cap$1,440.8M
15.5%
Peers median - 15.1%
11.8%
Peers median - 25.0%
20.4%
Peers median - 20.9%
3.7%
Peers median - 16.1%
Competing with ENFN
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$1,440.8M | 6.4 | $14.2 28.0% undervalued | 30.5% | $201.6M | $23.8M | 15.5% | 11.8% | 67.8% | 3.7% | 20.4% | |
$303.8B | 6.3 | $290.0 11.3% undervalued | 38.6% | €34.2B | €4,423.0M | 9.5% | 12.9% | 73.0% | 9.0% | 23.3% | |
$267.5B | 7.4 | $282.5 2.0% undervalued | (9.0%) | $37.9B | $12.4B | 8.7% | 32.8% | 77.2% | 9.4% | 18.6% | |
$168.1B | 7.6 | $345.2 57.3% overvalued | 6.8% | $11.0B | $3,385.0M | 22.4% | 30.8% | 79.2% | 18.9% | 7.0% | |
$163.6B | 6.8 | $629.0 7.2% undervalued | (9.3%) | $17.2B | $5,632.0M | 13.7% | 32.8% | 78.9% | 13.3% | 39.3% | |
$150.8B | 6.8 | $207.1 193.2% undervalued | (8.8%) | $44.0B | $6,951.0M | 18.0% | 15.8% | 37.5% | 56.9% | 44.4% | |
$120.1B | 7.7 | $34.0 63.4% overvalued | 24.0% | $8,879.6M | $1,596.3M | 25.8% | 18.0% | 50.4% | 67.0% | 16.0% | |
$85.1B | 7.7 | $139.5 45.9% overvalued | 329.4% | $4,709.2M | $2,094.2M | 43.4% | 44.5% | 74.5% | 49.8% | 326.3% | |
$64.7B | 7.0 | $319.5 31.5% undervalued | (8.9%) | $8,438.0M | $2,192.0M | 16.5% | 26.0% | 80.2% | 4.2% | 4.2% | |
$63.6B | 7.0 | $175.8 25.0% overvalued | (23.4%) | $4,641.3M | $1,118.0M | 13.5% | 24.1% | 91.5% | 24.3% | 53.0% | |
$54.4B | 6.4 | $24.2 90.7% overvalued | 75.6% | $463.5M | ($22.1B) | (6.6%) | (4,777.0%) | 72.1% | (4.6%) | 0.9% |
Compare ENFN Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Enfusion, Inc.ENFN
7.0x
15.5%
(81.2%)
1.4%
Median Peer Set
11.5x
14.9%
12.8%
17.3%
AppLovin CorporationAPP
18.7x
43.4%
363.4%
33.5%
Cadence Design Systems, Inc.CDNS
13.6x
13.5%
0.8%
22.7%
Salesforce, Inc.CRM
7.0x
8.7%
51.5%
16.4%
Intuit Inc.INTU
9.8x
13.3%
24.8%
18.2%
MicroStrategy IncorporatedMSTR
117.6x
(6.6%)
N/A
(251.7%)
ServiceNow, Inc.NOW
14.9x
22.4%
(18.4%)
13.0%
SAP SESAP
8.1x
9.6%
(49.0%)
9.1%
Shopify Inc.SHOP
13.1x
25.8%
1,470.0%
22.7%
Uber Technologies, Inc.UBER
3.5x
18.0%
423.3%
22.4%
Workday, Inc.WDAY
6.8x
16.4%
(62.5%)
6.2%
Compare ENFN Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Enfusion, Inc. (ENFN) revenue growth compare to peers and the industry?
Enfusion, Inc. (ENFN) revenue growth is 15.5%, compared to the peers' median of 15.1%.
2. How does Enfusion, Inc. (ENFN) Free Cash Flow (FCF) margin compare to peers and the industry?
Enfusion, Inc. (ENFN) FCF margin is 11.8%, compared to the peers' median of 25.0%.
3. How does Enfusion, Inc. (ENFN) Total Debt to Equity ratio compare to peers and the industry?
Enfusion, Inc. (ENFN) Total Debt to Equity ratio is 20.4%, compared to the peers' median of 20.9%.
4. How does Enfusion, Inc. (ENFN) ROIC (Return on Invested Capital) compare to peers and the industry?
Enfusion, Inc. (ENFN) ROIC is 3.7%, compared to the peers' median of 16.1%.